← brief for 2026-11-02 · Transplant & xeno

Innovative Management of Non-HLA Antibody and NK Cell-Mediated Rejection After Kidney Transplantation With Imlifidase: A Case Report

Paper No results yet Peer reviewed

Key takeaways

This report describes one patient who had a kidney transplant. The patient had a rare type of rejection that was hard to treat. Doctors used a new drug and testing method to manage the issue. This is a single case report, not a large study.

Source

Paper · AJKD · 2026-11-01
https://www.ajkd.org/article/S0272-6386(26)01193-5/fulltext?rss=yes